BPH-652,98.61%

产品编号:Bellancom-16115| CAS NO:157124-84-0| 分子式:C16H16K3O7PS| 分子量:500.63

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,

货号 包装 价格 库存与货期 购买量 操作
Bellancom-16115
8500.00 杭州 北京(现货)
Bellancom-16115
13000.00 杭州 北京(现货)

增值税发票√顺丰快递√订货电话:18601927057

BPH-652

产品介绍 BPH-652 是 CrtM 的抑制剂,Ki 值为 1.5 nM,IC50 值为100-300 nM (S. aureus 色素形成)。
生物活性

BPH-652 is a S. aureus dehydrosqualene synthase (CrtM) inhibitor, with a Ki of 1.5 nM and an IC50 of 100-300 nM (S. aureus pigment formation).

体外研究
体内研究

BPH-652 treatment (0.5 mg twice per day (days −1, 0, 1, and 2), Intraperitoneal injection) significantly lowers S. aureus bacterial counts in the kidneys of the mice than those of the control group (P < 0.001), with 8 of 13 below the detection threshold, versus only 2 of 14 in the control group; on average, this result corresponds to a 98% decrease in surviving bacteria in the treatment group.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: A systemic S. aureus infection model in mice.
Dosage: 0.5 mg twice per day (days −1, 0, 1, and 2).
Administration: Intraperitoneal injection.
Result: S. aureus bacterial counts in the kidneys of the mice treated with BPH-652 were significantly lower than those of the control group.
体内研究

BPH-652 treatment (0.5 mg twice per day (days −1, 0, 1, and 2), Intraperitoneal injection) significantly lowers S. aureus bacterial counts in the kidneys of the mice than those of the control group (P < 0.001), with 8 of 13 below the detection threshold, versus only 2 of 14 in the control group; on average, this result corresponds to a 98% decrease in surviving bacteria in the treatment group.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: A systemic S. aureus infection model in mice.
Dosage: 0.5 mg twice per day (days −1, 0, 1, and 2).
Administration: Intraperitoneal injection.
Result: S. aureus bacterial counts in the kidneys of the mice treated with BPH-652 were significantly lower than those of the control group.
性状Solid
溶解性数据
In Vitro: 

H2O : 25 mg/mL (49.94 mM; Need ultrasonic)

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 1.9975 mL 9.9874 mL 19.9748 mL
5 mM 0.3995 mL 1.9975 mL 3.9950 mL
10 mM 0.1997 mL 0.9987 mL 1.9975 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)。-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

4°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

参考文献

相关文档

化学品安全说明书(MSDS)

下载MSDS

质检证书(COA)

相关产品


服务热线

13911702513
18601927057

微信客服